Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.1 | - |
NAV | ₹31.16 | - |
Fund Started | 04 Dec 2015 | - |
Fund Size | ₹1339.00 Cr | - |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.1
-
NAV
₹31.16
-
Fund Started
04 Dec 2015
-
Fund Size
₹1339.00 Cr
-
Exit Load
Exit load of 0.25% if redeemed within 30 days.
-
Returns
1 Year | 4.93% | - |
3 Year | 23.80% | - |
5 Year | 18.97% | - |
1 Year
4.93%
-
3 Year
23.80%
-
5 Year
18.97%
-
Holding Analysis
Equity | 93.81% | - |
Cash | 6.19% | - |
Equity
93.81%
-
Cash
6.19%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.92% |
Cipla Ltd. | 6.62% |
Apollo Hospitals Enterprise Ltd. | 5.20% |
Lupin Ltd. | 4.77% |
Healthcare Global Enterprises Ltd. | 4.38% |
Torrent Pharmaceuticals Ltd. | 4.32% |
Aster DM Healthcare Ltd. | 4.32% |
Fortis Healthcare Ltd. | 4.00% |
Alkem Laboratories Ltd. | 4.00% |
Max Healthcare Institute Ltd. | 3.80% |
-
Fund Manager
Name | Meeta Shetty | - |
Start Date | 09 Nov 2018 | - |
Name
Meeta Shetty
-
Start Date
09 Nov 2018
-
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | - |
Launch Date | 04 Dec 2015 | - |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
-
Launch Date
04 Dec 2015
-
